Home » Thought Leadership » Research posters

Research posters

Read our insights and commentary about pharmaceutical industry news and healthcare innovation globally. Subscribe to our monthly newsletter to keep up to date with our thought leadership, news, and updates.

Showing 4 of 4 posts
ISPOR EU 2019: Access to Oncology Therapies in Russia and Visegrad Group Countries Infographic
November 4, 2019 | Research posters

ISPOR EU 2019: ICER – the Similarities and Differences Between UK (England) and USA Cost-Effectiveness Watchdogs

ISPOR EU 2019: CBPartners' EU Center of Excellence presented a poster which explores the similarities and differences between English and US cost-effectiveness watchdogs.

ISPOR EU 2019: Access to Oncology Therapies in Russia and Visegrad Group Countries Infographic
November 4, 2019 | Research posters

ISPOR EU 2019: Access to Oncology Therapies in Russia and Visegrad Group Countries

ISPOR EU 2019: CBPartners' CEE Center of Excellence presented a poster which looks at access to oncology therapies in Russia and Visegrad group countries.

ISPOR International 2019: Cross-Country ICER Evolution: What Does it Now Mean to be Cost-Effective?
May 12, 2019 | Research posters

ISPOR International 2019: The Importance of the Overall Survival Endpoint in EU HTA Decision-Making

ISPOR International 2019: CBPartners presented a research poster to describe the importance of the overall survival (OS) endpoint in EU HTA decision-making.

ISPOR International 2019: Cross-Country ICER Evolution: What Does it Now Mean to be Cost-Effective?
May 12, 2019 | Research posters

ISPOR International 2019: The Importance of Overall Survival as a Clinical Endpoint in FDA vs. EMA Regulatory Approval

ISPOR International 2019: CBPartners presented a poster about the importance of overall survival (OS) data as a clinical endpoint in FDA vs. EMA regulatory approval.